Electric Vehicle Infrastructure Program
Sector: Automotive • Location: Alabama, United States
Source: motopaddock.nl
The Electric Vehicle Infrastructure program, part of a $5 billion initiative, is facing disruptions due to a federal directive that halted the distribution of funds, requiring states to reevaluate their EV plans. This unexpected freeze impacts the development of a nationwide EV charging network, which is crucial for the transition to electric transportation in the U.S.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | Cancelled |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | The Electric Vehicle Infrastructure program, part of a $5 billion initiative, is facing disruptions due to a federal directive that halted the distribution of funds, requiring states to reevaluate their EV plans. This unexpected freeze impacts the development of a nationwide EV charging network, which is crucial for the transition to electric transportation in the U.S. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |
More Automotive projects in United States
- Kite Pharma’s Viral Vector Manufacturing Facility, California, US
- Virginia Cancer Specialists (VCS) Research Facility, Virginia
- Bristol-Myers Squibb Manufacturing Plant, Devens, Massachusetts
- Cambridge Major Laboratories Active Pharmaceutical
- LS Skaggs Pharmacy Institute, University of Utah, Salt Lake City
- Juno Therapeutics Headquarters and R&D Facility, Washington
- Eli Lilly’s Parenteral Product and Device Manufacturing Facility, Concord, North Carolina
- Amgen’s Drug Substance Manufacturing Plant, Wake County, North Carolina